Amicus joins gene therapy surge with $100M pipeline purchase

Published: 20/09/2018
Amicus joins gene therapy surge with $100M pipeline purchase
Source: WWW.FIERCEBIOTECH.COM

Amicus Therapeutics has paid $100 million to buy Celenex. The takeover gives Amicus a ready-made pipeline of 10 gene therapies, including two that are in clinical trials.

Read more
Related news
Comment